Top Markets
#1 Siren Siren +34.00%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.80%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.32%
#4 Wiki Cat Wiki Cat +18.11%
#5 Cysic Cysic +17.30%
#6 Velvet Velvet +17.16%
#7 PulseChain PulseChain +16.92%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.63%
#9 KUB Coin KUB Coin +14.94%
#10 Bitway Bitway +14.94%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rank in Stocks #31189
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Share Price
$0.03808538
Market Cap
$14.04M
Change (1 day)
-3.57%
Change (1 year)
6.63%
Country
AU
Trade BCAL Diagnostics Limited (BDX)

Category

Healthcare
Revenue for BCAL Diagnostics Limited (BDX)
Revenue in Aug 2026 TTM: 0
According to BCAL Diagnostics Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BCAL Diagnostics Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B -
US